Form 4: EcoR1 Capital, LLC Increases Stake in AnaptysBio, Inc. with $36.5 Purchase

EcoR1 Capital, LLC, along with Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P., reports an increase in their holdings of AnaptysBio, Inc. common stock through a purchase at $36.5 per share.

Summary

• EcoR1 Capital, LLC, Oleg Nodelman, and EcoR1 Capital Fund Qualified, L.P. filed a Form 4 detailing changes in their beneficial ownership of AnaptysBio, Inc. (ANAB) common stock.
• On August 14, 2024, Qualified Fund purchased 273,972 shares of ANAB at a price of $36.5 per share.
• Following the transaction, Qualified Fund holds 7,316,874 shares of AnaptysBio's Common Stock.
• The filers disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock ownership changes. The increase in stake could be seen as mildly positive, but without further context, it's difficult to gauge the overall sentiment.

Positives

• EcoR1 Capital's increased investment in AnaptysBio could be interpreted as a positive signal regarding their confidence in the company's future prospects.

Industry Context

This filing reflects ongoing investment activity in the biotechnology sector, where firms like EcoR1 Capital actively manage their portfolios and adjust their holdings based on their investment strategies and outlook on specific companies like AnaptysBio.

Stakeholder Impact

• The increased stake by EcoR1 Capital could positively influence shareholder confidence.

Key Dates